Comparing Integrative Interventions for Chronic Pelvic Pain

NCT ID: NCT07066345

Last Updated: 2025-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-12

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The researchers will conduct a pilot randomized trial to assess functional changes with two different remote integrative non-pharmacologic interventions for women with chronic pelvic pain (CPP). The study team will compare a novel web-based, cognitive-behavioral program designed for patients with CPP and a commercially available physical activity remote application. The team aims to gather information about differences in sexual function, physical function, pain, and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

My Pelvic Plan was determined as a medical device under FDA enforcement discretion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
Patients will be blinded to their group assignment. Study team members involved in outcome assessment will be blinded to group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1- My Pelvic Plan

Patients will be randomized to receive one of two non-pharmacologic interventions. Group 1 will receive access to a novel web-based, cognitive behavioral program.

Group Type EXPERIMENTAL

My Pelvic Plan

Intervention Type DEVICE

My Pelvic Plan is comprised of a self-guided program that combines education on several individual conditions that often contribute to CPP, and will include instruction on cognitive and behavioral restructuring techniques that can help to manage chronic pelvic pain symptoms.

Group 2- Bend

Patients will be randomized to receive one of two non-pharmacologic interventions. Group 2 will receive a subscription to a commercially available remote application.

Group Type ACTIVE_COMPARATOR

Bend

Intervention Type BEHAVIORAL

Bend is a highly rated physical activity application that helps guide users through gentle stretching and yoga poses.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

My Pelvic Plan

My Pelvic Plan is comprised of a self-guided program that combines education on several individual conditions that often contribute to CPP, and will include instruction on cognitive and behavioral restructuring techniques that can help to manage chronic pelvic pain symptoms.

Intervention Type DEVICE

Bend

Bend is a highly rated physical activity application that helps guide users through gentle stretching and yoga poses.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled for a new patient visit with the Chronic Pelvic Pain and Endometriosis Referral Clinic within the Department of Obstetrics and Gynecology at the University of Michigan for treatment of chronic pelvic pain.
* Have chronic pelvic pain, defined as moderate to severe pelvic pain that is ≥ 4 on a 0-10 numeric rating scale (worst pain during the day) for ≥ 6-month duration, and is non-cyclic, occurring for at least 14 days of each month.
* Report moderate to severe sexual dysfunction or sexual restriction on CPP clinic intake questionnaire. This will be defined as the patient indicating one of the following responses to a question that asks them to describe their experience relative to sexual activity: my sex life is nearly normal but is very painful, my sex life is severely restricted by pain, my sex life is nearly absent because of pain, pain prevents any self life at all.
* Have access to internet via computer and must have a smartphone
* Willing to download and use the Bend application on their smartphone if they are randomized to that intervention
* English-language proficiency (current version of the My Pelvic Plan website is in English)

Exclusion Criteria

* Pregnancy (at time of screening visit). Participants will be allowed to continue to study if they become pregnant during the study period.
* Severe physical impairment precluding participating in internet-based program or remote application (for example, complete blindness or deafness)
* Medical condition that precludes low-intensity, short-duration physical activity and gentle stretching, including cerebral palsy, severe hip or knee osteoarthritis, severe heart failure, severe Chronic obstructive pulmonary disease (COPD) requiring oxygen use
* Prior care within the Chronic Pelvic Pain and Endometriosis Referral Clinic within the Department of Obstetrics and Gynecology at the University of Michigan for treatment of chronic pelvic pain (seen previously but meets criteria for new patient visit because \> 3 year interval since last clinic visit).
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

Sponsor Role collaborator

Sara Till, MD, MPH

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sara Till, MD, MPH

Assistant Professor of Obstetrics and Gynecology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara Till, MD MPH

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Michigan

Ann Arbor, Michigan, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vilmarie Carmona

Role: CONTACT

269-760-7317

Sara Till

Role: CONTACT

734-232-1333

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K23HD099283

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HUM00273882

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Botox for Chronic Pelvic Pain
NCT06796985 RECRUITING PHASE1
HOme PElvic Floor Improvement Trainer Trial
NCT06909539 NOT_YET_RECRUITING NA